EA202092611A1 - APPLICATION DIAGRAM FOR THE TREATMENT OF PI3K-RELATED DISORDERS - Google Patents

APPLICATION DIAGRAM FOR THE TREATMENT OF PI3K-RELATED DISORDERS

Info

Publication number
EA202092611A1
EA202092611A1 EA202092611A EA202092611A EA202092611A1 EA 202092611 A1 EA202092611 A1 EA 202092611A1 EA 202092611 A EA202092611 A EA 202092611A EA 202092611 A EA202092611 A EA 202092611A EA 202092611 A1 EA202092611 A1 EA 202092611A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pi3k
treatment
related disorders
application diagram
diagram
Prior art date
Application number
EA202092611A
Other languages
Russian (ru)
Inventor
Кришнасвами Елесварам
Альберт Ассад
Сюэцзюнь Чэнь
Original Assignee
Инсайт Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Корпорейшн filed Critical Инсайт Корпорейшн
Priority claimed from PCT/US2019/034613 external-priority patent/WO2019232188A1/en
Publication of EA202092611A1 publication Critical patent/EA202092611A1/en

Links

Abstract

В изобретении представлены способы лечения расстройств, связанных с PI3K, с применением производных пиразолопиримидина.The invention provides methods of treating disorders associated with PI3K using pyrazolopyrimidine derivatives.

EA202092611A 2018-11-30 2019-05-30 APPLICATION DIAGRAM FOR THE TREATMENT OF PI3K-RELATED DISORDERS EA202092611A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862773612P 2018-11-30 2018-11-30
PCT/US2019/034613 WO2019232188A1 (en) 2018-06-01 2019-05-30 Dosing regimen for the treatment of pi3k related disorders

Publications (1)

Publication Number Publication Date
EA202092611A1 true EA202092611A1 (en) 2021-03-11

Family

ID=75262215

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092611A EA202092611A1 (en) 2018-11-30 2019-05-30 APPLICATION DIAGRAM FOR THE TREATMENT OF PI3K-RELATED DISORDERS

Country Status (1)

Country Link
EA (1) EA202092611A1 (en)

Similar Documents

Publication Publication Date Title
EA201800444A1 (en) DERIVATIVES OF MAYTANZINOID, THEIR CONJUGATES AND METHODS OF USE
EA201700464A1 (en) DERIVATIVES OF MAYTANZINOID, THEIR CONJUGATES AND METHODS OF USE
CO2017005784A2 (en) Fused bicyclic compounds for the treatment of diseases
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EA201990296A1 (en) ANTIBODIES AGAINST SIGLEC-7 FOR CANCER TREATMENT
EA201691872A1 (en) HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS
EA201890199A1 (en) COMBINED THERAPY FOR THE TREATMENT OF HEMOBLASTOSIS AND SOLID TUMORS
CO2017007121A2 (en) Fused bicyclic compounds for the treatment of diseases
EA202192151A1 (en) USE OF PYRAZOLE PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-RELATED DISORDERS
EA201692472A1 (en) CONNECTIONS FOR THE TREATMENT OF BRAIN CANCER
EA201890185A1 (en) METHODS OF TREATMENT OF DISEASES MEDIATED BY GEPSID
EA201991818A1 (en) CANCER TREATMENT
CL2019001381A1 (en) Method for the treatment of focal segmental glomerulosclerosis.
EA201792604A1 (en) AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
MX2018010993A (en) Icariin and icaritin derivatives.
EA201990400A1 (en) COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
ECSP20077106A (en) DOSING REGIME FOR THE TREATMENT OF PI3K-RELATED DISORDERS
EA201991360A1 (en) Modified Oligonucleotides for the Treatment of Polycystic Kidney Disease
EA201691412A1 (en) HYDROXYFORMAMIDE DERIVATIVES AND THEIR APPLICATION
CO2017010621A2 (en) Fused bicyclic compounds for the treatment of diseases
BR112019003130A2 (en) ppargam agonist for treatment of blood cancers
CL2021002318A1 (en) Methods of treating amyloidosis by
MX2018005987A (en) Heterocyclic compounds for the treatment of disease.
UY38352A (en) INTEGRIN INHIBITORS ALFAVBETA6
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE